Cite
HARVARD Citation
Suvannasankha, A. et al. (n.d.). P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY. HemaSphere. pp. 830-831. [Online].